| DIRECT COMPETITOR COMPARISON | |
| LIFE | AFFX | A | Pvt1 | Industry | | Market Cap: | 8.88B | 330.42M | 9.92B | N/A | 100.26M | | Employees: | 9,700 | 1,128 | 17,000 | N/A | 68 | | Qtrly Rev Growth (yoy): | 121.40% | 4.00% | -21.20% | N/A | 19.70% | | Revenue (ttm): | 2.95B | 316.88M | 4.48B | 1.03B1 | 14.01M | | Gross Margin (ttm): | 64.07% | 51.26% | 51.15% | N/A | 65.67% | | EBITDA (ttm): | 818.22M | 1.48M | 209.00M | N/A | -12.30M | | Oper Margins (ttm): | 15.72% | -15.92% | 1.05% | N/A | -149.46% | | Net Income (ttm): | 7.87M | -345.42M | -31.00M | N/A | N/A | | EPS (ttm): | 0.049 | -5.037 | -0.090 | N/A | -0.33 | | P/E (ttm): | 1015.71 | N/A | N/A | N/A | 16.37 | | PEG (5 yr expected): | 1.48 | N/A | 1.6 | N/A | 1.31 | | P/S (ttm): | 3.02 | 1.06 | 2.23 | N/A | 9.35 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.4428 | -0.10% | 57.13B | 12.31 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.052 | 0.28% | 13.61B | 15.75 | | Genzyme Corp. | GENZ | 50.89 | -0.35% | 13.51B | 29.01 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.1701 | -0.84% | 41.55B | 17.85 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.77 | -0.36% | 8.88B | 1015.71 | | Teva Pharmaceutical Industries Limited | TEVA | 52.76 | -0.23% | 46.48B | 48.27 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.39 | 1.16% | 3.97B | 19.27 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | -1.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.90 | -0.61% | 5.47B | 109.82 | | Pfizer Inc. | PFE | 18.29 | 0.22% | 147.59B | 15.19 | | Johnson & Johnson | JNJ | 62.3926 | -0.79% | 172.15B | 13.63 | | GlaxoSmithKline plc | GSK | 41.22 | -2.46% | 104.49B | 13.09 | | Sanofi-Aventis | SNY | 37.75 | -1.77% | 98.57B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.42 | 0.07% | 125.87B | 16.59 | | RHHBY.PK | 40.79 | -1.62% | N/A | N/A | | AstraZeneca plc | AZN | 44.56 | -1.61% | 64.61B | 8.95 | | Abbott Laboratories | ABT | 53.99 | -0.17% | 83.51B | 14.63 | | Bristol-Myers Squibb Co. | BMY | 25.42 | 0.16% | 50.36B | 13.15 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | A | | TRADE NEWS: Agilent Technologies Introduces Monolithic Laser Combiner System for Confocal and Fluorescence Microscopy
Mon 11:00am -
Business Wire | | • | AFFX | | Luminex Posts Loss
Mon 10:14am -
Zacks.com | | • | A | | Zacks Bull and Bear of the Day Highlights: Agilent Technologies, The Medicines Company, Alcoa, U.S. Steel and Freeport McMoRan
Fri, Nov 27 -
Zacks.com | | • | A | | Zacks #1 Rank Additions for Friday
Fri, Nov 27 -
Zacks.com | | • | A | | Agilent Technologies (A)
Fri, Nov 27 -
Zacks.com | | • | A | | EU mergers and takeovers (Nov 26)
Thu, Nov 26 -
at Reuters | | • | A | | Agilent Technologies to Present at Credit Suisse Annual Technology Conference
Wed, Nov 25 -
Business Wire | | • | A | | StockPreacher.com Issues Trading Overview for TTI Team Telecom International Ltd.
Wed, Nov 25 -
GlobeNewswire | | • | AFFX | | Affymetrix to Webcast Presentation at the 23rd NASDAQ OMX Investor Forum
Wed, Nov 25 -
Business Wire | | • | A | | AGILENT TECHNOLOGIES INC Files SEC form 8-K, Other Events
Tue, Nov 24 -
EDGAR Online | | • | AFFX | | CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
Thu, Nov 19 -
at Seeking Alpha | | • | AFFX | | Trading Overview for Sequenom Inc. Issued by StockPreacher.com
Tue, Nov 17 -
GlobeNewswire | | • | AFFX | | AFFYMETRIX INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | AFFX | | Fearful Stocks for Greedy Investors
Tue, Nov 10 -
at Motley Fool | | • | AFFX | | AFFYMETRIX INC Files SEC form 10-Q, Quarterly Report
Fri, Nov 6 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
0.36% Nasdaq 
Competitors
